{"id":"https://genegraph.clinicalgenome.org/r/9c1c1a3b-c61a-47bd-82cb-c5a6a55a4adfv1.0","type":"EvidenceStrengthAssertion","dc:description":"CDK4 was the second high risk melanoma susceptibility gene identified . CDK4 is an oncogene located within the 12q14 chromosomal region and encodes a protein that controls cell cycle progression through the G1 phase. To date mutations in this gene have been described in 17 melanoma-prone families and in all of them the mutation affects the same amino acid (Arginine 24): p.Arg24Cys and p.Arg24His (Potrony M, et al. 2015. PMID: 26488006). These R24C and R24H mutations lead to CDK4 behaving as a dominant oncoprotein through loss of binding to p16, its negative regulator. Thus, when CDK4 is mutated, p16INK4A cannot inhibit the CDK4 kinase activity resulting in the progression of the cell cycle.  In an analysis of 17 families, median age at first melanoma diagnosis was 39 years, and the lifetime mutation penetrance based on the available data was estimated at 74%(Read J, et al. 2016.PMID: 26337759). Phenotypically, individuals with CDK4 mutations cannot be distinguished from those with CDKN2A mutations . Both mutations are characterized by numerous atypical nevi and multiple primary melanomas.(Lee KC, et al. 2015. PMID:30190834).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/9c1c1a3b-c61a-47bd-82cb-c5a6a55a4adf","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ca76579b-1432-4edc-84e8-b3332dce4ede","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ca76579b-1432-4edc-84e8-b3332dce4ede_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-01-13T19:44:34.667Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/ca76579b-1432-4edc-84e8-b3332dce4ede_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca76579b-1432-4edc-84e8-b3332dce4ede_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca76579b-1432-4edc-84e8-b3332dce4ede_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b271e50c-e197-40d3-9884-2e722fbb0d7a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"CDK4 Arg24His is one of the most familial CDK4 variants, with known gain of function of CDK4. p16INK4A cannot inhibit the CDK4 kinase activity resulting in the progression of the cell cycle. CDK4  Arg24Cys mutation carriers phenotypically behave similarly to p16INK4A mutation carriers","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7b10523-dfe4-4692-844a-f256de3f4c94","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","rdfs:label":"Australia-1 proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"CDK4 gene sequence","firstTestingMethod":"Sanger sequencing","phenotypes":"obo:HP_0002861","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/b271e50c-e197-40d3-9884-2e722fbb0d7a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","allele":{"id":"https://genegraph.clinicalgenome.org/r/3571f008-fd70-4a9c-9a2d-4bed7300cee3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000075.4(CDK4):c.71G>A (p.Arg24His)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16929"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/079b079f-ba41-48ca-bd10-c167c9cba0ed_proband_score_evidence_line","type":"EvidenceLine","dc:description":"CDK4 Arg24Cys is one of the most familial CDK4 variants, with known gain of function of CDK4. p16INK4A cannot inhibit the CDK4 kinase activity resulting in the progression of the cell cycle. CDK4  Arg24Cys mutation carriers phenotypically behave similarly to p16INK4A mutation carriers","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da333740-96cf-4e8c-985c-eaaac5ebcba5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528263","rdfs:label":"II-1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Single-strand conformation polymorphism (SSCP) for all family member, Proband's PCR result was cloned and sequenced and found  nucleotide 297 C>T (not correct HGVS, it should be c.70C>T) ,  result in Arg24Cys","firstTestingMethod":"SSCP","phenotypes":"obo:HP_0012056","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/079b079f-ba41-48ca-bd10-c167c9cba0ed_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528263","allele":{"id":"https://genegraph.clinicalgenome.org/r/4092434c-7853-4586-8f16-93bfe7d8a23b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000075.4(CDK4):c.70C>T (p.Arg24Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16928"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ef927ef7-88bc-43d7-9410-e5dd1923522d_proband_score_evidence_line","type":"EvidenceLine","dc:description":"CDK4 Arg24His is one of the most familial CDK4 variants, with known gain of function of CDK4. p16INK4A cannot inhibit the CDK4 kinase activity resulting in the progression of the cell cycle.Variant segregated with disease in this huge family.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1bc7f347-bc23-452a-a78a-0dd707ce8a12","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15880589","rdfs:label":"III‐12, IV‐1, IV‐2, and IV‐22","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"sequence coding CDK4 exons 2–8  on  from the genomic DNA of four family members (subjects III‐12, IV‐1, IV‐2, and IV‐22)","firstTestingMethod":"Sanger sequencing","phenotypes":"obo:HP_0002861","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ef927ef7-88bc-43d7-9410-e5dd1923522d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15880589","allele":{"id":"https://genegraph.clinicalgenome.org/r/3571f008-fd70-4a9c-9a2d-4bed7300cee3"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/46a0a1b1-32e1-499f-907b-e7b3d295e744_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a1f0613-790d-41ae-ba14-597643628853","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","rdfs:label":"Latvia-3-M679","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Sanger sequencing","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/46a0a1b1-32e1-499f-907b-e7b3d295e744_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","allele":{"id":"https://genegraph.clinicalgenome.org/r/3571f008-fd70-4a9c-9a2d-4bed7300cee3"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d8f56aef-8040-4364-a32e-f468eb712f9d_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1806b9f4-48e7-45f6-9b34-131d56e71a3a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9425228","rdfs:label":"III-5","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Start with CDK4 exon 2 SSCP, then positive PCR product was sequenced.","firstTestingMethod":"SSCP","phenotypes":"obo:HP_0002861","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d8f56aef-8040-4364-a32e-f468eb712f9d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9425228","allele":{"id":"https://genegraph.clinicalgenome.org/r/3571f008-fd70-4a9c-9a2d-4bed7300cee3"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ea792cdb-11b1-4391-a31a-c0521b4db1a2_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a6447cb9-c2c3-498e-81c4-d0e4137af9de","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","rdfs:label":"Latvia-2-268-proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Linkage analysis","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/ea792cdb-11b1-4391-a31a-c0521b4db1a2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","allele":{"id":"https://genegraph.clinicalgenome.org/r/3571f008-fd70-4a9c-9a2d-4bed7300cee3"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/65decf83-c576-4975-af93-84b5daac4441_proband_score_evidence_line","type":"EvidenceLine","dc:description":"CDK4 Arg24Cys is one of the most familial CDK4 variants, with known gain of function of CDK4. p16INK4A cannot inhibit the CDK4 kinase activity resulting in the progression of the cell cycle. CDK4  Arg24Cys mutation carriers phenotypically behave similarly to p16INK4A mutation carriers","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c635ab3c-95c1-4fb1-8af1-e32594edb3d0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528263","rdfs:label":"B II-1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Same as family 342. SSCP, then cloned PCR product and then sequencing","firstTestingMethod":"SSCP","phenotypeFreeText":"familial melanoma","phenotypes":"obo:HP_0002861","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/65decf83-c576-4975-af93-84b5daac4441_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528263","allele":{"id":"https://genegraph.clinicalgenome.org/r/4092434c-7853-4586-8f16-93bfe7d8a23b"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/7d60829b-8837-4683-a684-8b2a823afe43_proband_score_evidence_line","type":"EvidenceLine","dc:description":"CDK4 Arg24Cys is one of the two familial CDK4 variants, with known gain of function of CDK4. p16INK4A cannot inhibit the CDK4 kinase activity resulting in the progression of the cell cycle. CDK4  Arg24Cys mutation carriers phenotypically behave similarly to p16INK4A mutation carriers","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9432d136-19f2-4037-aab0-03d21ff836d0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","rdfs:label":"UK-2-1119 proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Sanger sequencing","phenotypes":"obo:HP_0002861","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/7d60829b-8837-4683-a684-8b2a823afe43_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","allele":{"id":"https://genegraph.clinicalgenome.org/r/4092434c-7853-4586-8f16-93bfe7d8a23b"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/059cc8a4-313a-4439-b96b-8941d38ac197_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e531f615-bfa8-4c86-995b-d6de096beba3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","rdfs:label":"Latvia-1-247","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Sanger sequencing","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/059cc8a4-313a-4439-b96b-8941d38ac197_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","allele":{"id":"https://genegraph.clinicalgenome.org/r/3571f008-fd70-4a9c-9a2d-4bed7300cee3"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a4a05d3e-d762-43e7-b0e0-1d222de01eb1_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce67e061-da12-43a6-860e-e2fe7ef93c29","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","rdfs:label":"UK-1-301_proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"CDK4 gene sequencing","firstTestingMethod":"Sanger sequencing","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/a4a05d3e-d762-43e7-b0e0-1d222de01eb1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","allele":{"id":"https://genegraph.clinicalgenome.org/r/3571f008-fd70-4a9c-9a2d-4bed7300cee3"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":7},{"id":"https://genegraph.clinicalgenome.org/r/ca76579b-1432-4edc-84e8-b3332dce4ede_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d5b13cb-3543-4c20-9abf-e37857f858b6_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","rdfs:label":"UK-1-301","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/0d5b13cb-3543-4c20-9abf-e37857f858b6","type":"Family","rdfs:label":"UK-1-301","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/ce67e061-da12-43a6-860e-e2fe7ef93c29"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0002861","proband":{"id":"https://genegraph.clinicalgenome.org/r/ce67e061-da12-43a6-860e-e2fe7ef93c29"}},{"id":"https://genegraph.clinicalgenome.org/r/3fb8033b-6e55-4ace-9e9a-0235b8640d14_proband_segregation","type":"FamilyCosegregation","dc:description":"No detail pedigree info","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","rdfs:label":"UK-2-1119","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/3fb8033b-6e55-4ace-9e9a-0235b8640d14","type":"Family","rdfs:label":"UK-2-1119","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9432d136-19f2-4037-aab0-03d21ff836d0"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":4,"phenotypes":"obo:HP_0002861","proband":{"id":"https://genegraph.clinicalgenome.org/r/9432d136-19f2-4037-aab0-03d21ff836d0"}},{"id":"https://genegraph.clinicalgenome.org/r/e8b0ceab-ee80-4821-b6fb-c3b8d9556872_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","rdfs:label":"Latvia-2-268","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/e8b0ceab-ee80-4821-b6fb-c3b8d9556872","type":"Family","rdfs:label":"Latvia-2-268","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/a6447cb9-c2c3-498e-81c4-d0e4137af9de"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/a6447cb9-c2c3-498e-81c4-d0e4137af9de"}},{"id":"https://genegraph.clinicalgenome.org/r/ab222e61-8208-45b5-8d96-b76d03d224ed_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9425228","rdfs:label":"Family 759","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/ab222e61-8208-45b5-8d96-b76d03d224ed","type":"Family","rdfs:label":"Family 759","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/1806b9f4-48e7-45f6-9b34-131d56e71a3a"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"melanoma","phenotypePositiveAllelePositive":6,"phenotypes":"obo:HP_0002861","proband":{"id":"https://genegraph.clinicalgenome.org/r/1806b9f4-48e7-45f6-9b34-131d56e71a3a"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/01a19ac3-9e34-49f3-b21f-cb5502fb5907_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528263","rdfs:label":"Family 2905","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/01a19ac3-9e34-49f3-b21f-cb5502fb5907","type":"Family","rdfs:label":"Family 2905","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/c635ab3c-95c1-4fb1-8af1-e32594edb3d0"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":5,"phenotypes":"obo:HP_0002861","proband":{"id":"https://genegraph.clinicalgenome.org/r/c635ab3c-95c1-4fb1-8af1-e32594edb3d0"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/0e683651-e004-45b0-8f35-1ccd41f49149_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","rdfs:label":"Latvia-1-247","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/0e683651-e004-45b0-8f35-1ccd41f49149","type":"Family","rdfs:label":"Latvia-1-247","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/e531f615-bfa8-4c86-995b-d6de096beba3"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/e531f615-bfa8-4c86-995b-d6de096beba3"}},{"id":"https://genegraph.clinicalgenome.org/r/00744be6-53bf-4cfd-bfdb-ea4351a8f29a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528263","rdfs:label":"Family 342","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/00744be6-53bf-4cfd-bfdb-ea4351a8f29a","type":"Family","rdfs:label":"Family 342","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/da333740-96cf-4e8c-985c-eaaac5ebcba5"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"familial melanoma","phenotypePositiveAllelePositive":7,"proband":{"id":"https://genegraph.clinicalgenome.org/r/da333740-96cf-4e8c-985c-eaaac5ebcba5"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/25d80446-4a50-4bc5-b03b-eb4d53b8e2fc_proband_segregation","type":"FamilyCosegregation","dc:description":"Less than 4 affected family member","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","rdfs:label":"Australia-1-60007","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/25d80446-4a50-4bc5-b03b-eb4d53b8e2fc","type":"Family","rdfs:label":"Australia-1-60007","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/e7b10523-dfe4-4692-844a-f256de3f4c94"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0002861","proband":{"id":"https://genegraph.clinicalgenome.org/r/e7b10523-dfe4-4692-844a-f256de3f4c94"}},{"id":"https://genegraph.clinicalgenome.org/r/deca17e1-0804-4d78-b050-3f4d68daf19e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23384855","rdfs:label":"Latvia-3-M679","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/deca17e1-0804-4d78-b050-3f4d68daf19e","type":"Family","rdfs:label":"Latvia-3-M679","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/5a1f0613-790d-41ae-ba14-597643628853"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/5a1f0613-790d-41ae-ba14-597643628853"}},{"id":"https://genegraph.clinicalgenome.org/r/a06fb641-bd0a-40e1-9a55-2ca98d453202_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15880589","rdfs:label":"Norway-1","estimatedLodScore":8.13,"family":{"id":"https://genegraph.clinicalgenome.org/r/a06fb641-bd0a-40e1-9a55-2ca98d453202","type":"Family","rdfs:label":"Norway-1","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/1bc7f347-bc23-452a-a78a-0dd707ce8a12"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"many cases of malignant melanoma, some of whose members also had multiple, clinically atypical nevi","phenotypePositiveAllelePositive":28,"phenotypes":"obo:HP_0002861","proband":{"id":"https://genegraph.clinicalgenome.org/r/1bc7f347-bc23-452a-a78a-0dd707ce8a12"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":8.5},{"id":"https://genegraph.clinicalgenome.org/r/ca76579b-1432-4edc-84e8-b3332dce4ede_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca76579b-1432-4edc-84e8-b3332dce4ede_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cbdefa0f-6df1-487a-8f9d-aef0dd4a2064","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/22908894-ffa3-4176-965c-decd0a7fdba1","type":"Finding","dc:description":"By 8 to 10 months, homozygous Cdk4R24C/R24C mice developed tumors in multiple organs,\nclearly demonstrating the consequence of deregulated Cdk4 expression","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11756559","rdfs:label":"CDK4  R24C/R24C mutation homozygous mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4a5b36f5-2ac5-4783-9b1a-b1d9ceea735b","type":"EvidenceLine","dc:description":"Systemic in-vitro study to indicate CDK4 R24C is present as gain of function during tumorigenesis.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05efceba-4548-4f91-aa98-748cd013f5ce","type":"Finding","dc:description":"Cdk4R24C/R24C mouse embryo fibroblasts (MEFs) displayed increased Cdk4 kinase\nactivity resulting in hyperphosphorylation of all three members of the Rb family, pRb, p107, and p130. MEFs derived from Cdk4R24C/R24C mice displayed decreased doubling times, escape from replicative senescence, and escape sensitivity to contact-induced growth arrest. These MEFs also exhibited a high degree of susceptibility to oncogene-induced transformation, suggesting that the Cdk4R24C mutation can serve as a primary event in\nthe progression towards a fully transformed phenotype","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11756559","rdfs:label":"Cdk4 R24C/R24C mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/ca76579b-1432-4edc-84e8-b3332dce4ede_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b4f01a5-19ab-4b77-9646-60dc10d6f7a6","type":"EvidenceLine","dc:description":"Combined protein binding and downstream kinase assay to prove the mechanism of CDK4 mutant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4a6d27e-8924-4834-aea1-968e70e237ff","type":"FunctionalAlteration","dc:description":"both CDK4-wt and CDK4-R24C were enzymatically active in the presence of cyclin Dl, and both were inhibited by p27 and p21. CDK4-R24C was considerably less sensitive to inhibition by p16 sup INK4a than was the wild-type enzyme.(Fig. 5B). Similarly, p15 sup INK4b a member of the INK4 family of inhibitors (19), did not form a stable complex with CDK4-R24C and did not effectively inhibit its kinase activity (20). These results indicate that CDK4-R24C is selectively impaired in its interaction with p16 sup INK4a and p15 sup INK4b and suggest that Arg sup 24 is directly involved in binding to p16 sup INK4a and p15 sup INK4b .","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7652577","rdfs:label":"kinase assays"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/73495bb5-a3c8-4a35-aa55-839be345770b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/465b3af7-73a6-47b3-a406-ab0bc515224d","type":"FunctionalAlteration","dc:description":"Knock-down of CDK4 or CDK6 results in reduced migration, decreases tumor growth, reduces subcutaneous tumor formation; reduces VEGF-A secretion/ production. The availability of CDK6 at the VEGF promoter depends on the presence of CDK4","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30858922","rdfs:label":"shRNA inhibition assay"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ca76579b-1432-4edc-84e8-b3332dce4ede_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96b49b6f-9a94-4abf-8e58-bb4e4e7b36c9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b668e6b2-6668-4cc5-bb96-7d74956c099b","type":"Finding","dc:description":"Immunoprecipitation with antibodies to CDK4 showed that CDK4-R24C formed stable complexes with cyclin D1, p27, and p21, but not with p16 sup INK4a","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7652577","rdfs:label":"Immunoprecipitation with antibodies to CDK4","demonstrates":{"id":"obo:MI_0208"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":639,"specifiedBy":"GeneValidityCriteria7","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/aTb9sy09cv0","type":"GeneValidityProposition","disease":"obo:MONDO_0012183","gene":"hgnc:1773","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ca76579b-1432-4edc-84e8-b3332dce4ede-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}